{"id":"NCT01489254","sponsor":"Synthon BV","briefTitle":"Efficacy and Safety of GTR in Comparison to Copaxone®","officialTitle":"Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group, 9 Month, Equivalence Trial Comparing the Efficacy and Safety and Tolerability of GTR (Synthon BV) to Copaxone® (Teva) in Subjects With Relapsing Remitting Multiple Sclerosis Followed by an Open-label 15 Month GTR Treatment Part Evaluating the Long-term GTR Treatment Effects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2015-01","completion":"2015-01","firstPosted":"2011-12-09","resultsPosted":"2016-10-31","lastUpdate":"2016-12-29"},"enrollment":794,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"Glatiramer Acetate (GTR)","otherNames":[]},{"type":"DRUG","name":"Glatiramer Acetate (Copaxone®)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"GTR","type":"EXPERIMENTAL"},{"label":"Copaxone®","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is demonstrate that efficacy and safety of Synthon's glatiramer acetate (GTR) is equivalent to Copaxone® (Teva) in patients with relapsing remitting multiple sclerosis","primaryOutcome":{"measure":"The Number of T1-Gadolinium Enhancing Lesions During Months 7-9","timeFrame":"9 months","effectByArm":[{"arm":"Glatiramer 20 mg","deltaMin":0.42,"sd":null},{"arm":"Copaxone 20 mg","deltaMin":0.38,"sd":null},{"arm":"Placebo","deltaMin":0.82,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":12},"locations":{"siteCount":133,"countries":["United States","Belarus","Bosnia and Herzegovina","Bulgaria","Croatia","Czechia","Estonia","Georgia","Germany","Italy","Mexico","Moldova","Poland","Romania","Russia","Serbia","South Africa","Ukraine","United Kingdom"]},"refs":{"pmids":["26458034"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":353},"commonTop":["Injection site reaction","Nasopharyngitis","Immediate post-injection reaction","Headache","Injection site swelling"]}}